Cyprus: Hormones, Prostaglandins, Thromboxanes And Leukotrienes - Market Report. Analysis And Forecast To 2025
All reports
Store / Pharmaceutical Products / Pharmaceuticals, Medicinal Chemical And Botanical Products
-
Format: Electronic (PDF) by email
(July 20, 2017)
EUR 1490
Download a FREE Sample NOW
- Description
-
The report provides an in-depth analysis of the hormone market in Cyprus. It presents the latest data of the market size and volume, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify the key drivers and restraints. You can find here a strategic analysis of key factors influencing the market. Forecasts illustrate how the market will be transformed in the medium term. Profiles of the leading companies and brands are also included.
Countries coverage: Cyprus
Product coverage: Hormones, prostaglandins, thromboxane and leukotriene, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones. These products should be understood as organic compounds (they belong to HS chapter 29), not as ready to be used as pharmaceutical products/medicaments. In this sense the products making up the code 35250-2 are distinct from medicaments containing them.
Data coverage:
• Hormone market size and value in Cyprus
• Volume and dynamics of hormone production in Cyprus
• Volume and dynamics of exports/imports
• Producer prices, import/export prices for hormone
• Hormone market trends, drivers and restraints
• Forecast of the market dynamics in the medium term
• Per capita consumption of hormone in Cyprus
Why buy this report'
• Get the full picture of the market
• Identify Key success factors on the plaiting material market in Cyprus
• Adjust your marketing strategy
- Table of Contents
-
1. INTRODUCTION
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY
2. EXECUTIVE SUMMARY
2.1 KEY FINDINGS
2.2 MARKET TRENDS
3. MARKET OVERVIEW
3.1 MARKET VOLUME AND VALUE
3.2 TRADE BALANCE
3.3 PER CAPITA CONSUMPTION
3.4 MARKET OPPORTUNITIES
3.5 MARKET FORECAST TO 2025
3.6 MARKET OPPORTUNITIES
4. PRODUCTION
4.1 PRODUCTION FROM 2007-2016
5. IMPORTS
5.1 IMPORTS FROM 2007-2016
5.2 IMPORTS BY COUNTRY
5.3 IMPORT PRICES BY COUNTRY
6. EXPORTS
6.1 EXPORTS FROM 2007-2016
6.2 EXPORTS BY COUNTRY
6.3 EXPORT PRICES BY COUNTRY
7. PRICES AND PRICE DEVELOPMENT
7.1 PRODUCER PRICES ON THE DOMESTIC MARKET
7.2 PRODUCER PRICES ON THE NON-DOMESTIC MARKET
8. TRADE STRUCTURE AND CHANNELS
8.1 MAJOR TRADE CHANNELS
8.2 PRICE STRUCTURE
9. BUSINESS ENVIRONMENT OVERVIEW
9.1 STRUCTURAL PROFILE
9.2 COUNTRY ANALYSIS
9.3 SIZE CLASS ANALYSIS
Appendix 1: Trade and Prices by Country
LIST OF TABLES
Table 1: Key Findings in 2016
Table 2: Market Volume, in Physical Terms, 2007-2016
Table 3: Market Value, in Value Terms, 2007-2016
Table 4: Per Capita Consumption of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in 2007-2016
Table 5: Comparison of Consumption, Production and Imports
Table 6: Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, in Physical And Value Terms, by Country, 2007-2016
Table 7: Import Prices, by Type and Country of Origin, 2007-2016
Table 8: Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, in Physical And Value Terms, by Country, 2007-2016
Table 9: Export Prices, by Type and Country of Destination, 2007-2016
Table 10: Producer Prices, 2016, by Country
Table 11: Producer Prices in Industry, Domestic Market - Monthly Data (2010 = 100), by Country
Table 12: Producer Prices in Industry, Domestic Market - Annual Data (2010 = 100), by Country
Table 13: Producer Prices in Industry, Non-Domestic Market - Monthly Data (2010 = 100), by Country
Table 14: Producer Prices in Industry, Non-Domestic Market - Annual Data (2010 = 100), by Country
Table 15: Key Indicators, 2015
Table 16: Largest and Most Specialised Countries
Table 17: Number of Persons Employed by Enterprise Size Class, 2015
Table 18: Value Added by Enterprise Size Class, 2015
LIST OF FIGURES
Figure 1: Market Volume, in Physical Terms, 2007-2016
Figure 2: Market Value, in Value Terms, 2007-2016
Figure 3: Market Structure – Domestic Supply Vs. Imports, in Physical Terms, 2007-2016
Figure 4: Market Structure – Domestic Supply Vs. Imports, in Value Terms, 2007-2016
Figure 5: Trade Balance, in Physical Terms, 2007-2016
Figure 6: Trade Balance, in Value Terms, 2007-2016
Figure 7: Per Capita Consumption of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, 2007-2016
Figure 8: Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes by Country, Growth Rate and Share of Consumption
Figure 9: Market Growth Vs. Share of Imports
Figure 10: Market Forecast to 2025
Figure 11: Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, in Physical Terms, 2007–2016
Figure 12: Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, in Value Terms, 2007–2016
Figure 13: Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, in Physical Terms, 2007-2016
Figure 14: Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, in Value Terms, 2007-2016
Figure 15: Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, in Physical Terms, by Country, 2016
Figure 16: Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, in Physical Terms, by Country, 2007-2016
Figure 17: Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, in Value Terms, by Country, 2007-2016
Figure 18: Import Prices, by Type, 2007-2016
Figure 19: Import Prices, by Country of Origin, 2007-2016
Figure 20: Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, in Physical Terms, 2007-2016
Figure 21: Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, in Value Terms, 2007-2016
Figure 22: Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, in Physical Terms, by Country, 2016
Figure 23: Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, in Physical Terms, by Country, 2007-2016
Figure 24: Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes, in Value Terms, by Country, 2007-2016
Figure 25: Export Prices, by Type, 2007-2016
Figure 26: Export Prices, by Country of Destination, 2007-2016
Figure 27: Producer Prices in Industry - Domestic Output Price Index - in National Currency
Figure 28: Producer Prices in Industry – Non-Domestic Output Price Index - in National Currency
Figure 29: Relative Importance of Enterprise Size Classes, 2015
